Maharashtra, India

Galge Revanappa

This inventor holds 1 USPTO granted patent. Top assignee: Piramal Enterprises Limited. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Galge Revanappa. Retrieved from https://idiyas.com/inventor/galge-revanappa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Galge Revanappa in Pharmaceutical Chemistry

Introduction

Galge Revanappa is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important compounds used in medication.

Latest Patents

Revanappa holds a patent for a process titled "Process for the preparation of lurasidone and its intermediate." This invention provides an improved method for preparing a key intermediate compound, which is essential for synthesizing lurasidone, a medication used to treat schizophrenia. The process involves the reaction of specific compounds in the presence of a solvent mixture and a base, resulting in a product with high purity and minimal impurities.

Career Highlights

Galge Revanappa is associated with Piramal Enterprises Limited, a leading company in the pharmaceutical sector. His work focuses on developing innovative processes that enhance the efficiency and effectiveness of drug synthesis.

Collaborations

Revanappa has collaborated with notable colleagues, including Milind Moreshwar Gharpure and Shashi Kant Tiwari. These collaborations have contributed to the advancement of research and development in the pharmaceutical industry.

Conclusion

Galge Revanappa's contributions to pharmaceutical chemistry, particularly through his patent on lurasidone synthesis, highlight his innovative spirit and dedication to improving drug development processes. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…